Author

R. J. Liang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. J. Lazar· 1 shared A. L. Queiroz· 1 shared A. Murthy· 1 shared B. D. Stein· 1 shared B. Ngo· 1 shared D. Wu· 1 shared E. Dantas· 1 shared E. E. Gardner· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Lazar

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer.

H. T. Langer, S. Ramsamooj, E. Dantas, A. Murthy, M. Ahmed, S.-K. Hwang, R. Grover, R. Pozovskiy, R. J. Liang, A. L. Queiroz, J. C. Brown, E. P. White, T. Janowitz, M. D. Goncalves

This study shows that rosiglitazone restores adiponectin levels and preserves tissue mass in mice with lung cancer by enhancing AMPK and AKT activity.

bioRxiv · Jul 31, 2023Cancer Biology

Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma

G. Romano, F. Paradiso, P. Li, P. Shukla, L. N. Barger, O. El Naggar, J. P. Miller, R. J. Liang, T. L. Helms, A. J. Lazar, J. A. Wargo, F. Taraballi, J. C. Costello, L. N. Kwong

The paper shows that delivering Cxcl9 via microparticles enhances the effectiveness of BRAF inhibitors in melanoma by reducing minimal residual disease relapse.

bioRxiv · May 24, 2022Cancer Biology

Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma

B. D. Stein, J. R. Ferrarone, E. E. Gardner, J. W. Chang, D. Wu, Q. Chen, P. E. Hollstein, M. Yuan, R. J. Liang, J. S. Coukos, M. Sindelar, B. Ngo, S. S. Gross, R. J. Shaw, J. M. Asara, , L. C. Cantley

This study identifies a metabolic divergence between human and mouse lung adenocarcinomas due to LKB1-dependent regulation of TPI1 phosphorylation, highlighting limitations of mouse models for studying human cancer.

bioRxiv · Oct 1, 2021 · PreprintCancer Biology